A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
INTERNATIONAL PATENT: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS EYE AND EAR INFIRMARY, BANNER HEALTH FILES APPLICATION FOR "COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE"
Published:
April 23, 2024
by U.S. Fed News
|
European Commission approves Jannsen's CARVYKTI ciltacabtagene autoleucel cilta-cel for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy; it is the first BCMA-targeted treatment approved by the EC
Published:
April 22, 2024
by Janssen Pharmaceutical Companies
|
HI SCR81: Urging The Governor To Ensure That Relevant State Agencies, Including The Department Of Health And Department Of Human Services, Collaborate To Explore Avenues To Ensure Continued Access To ...
Published:
April 22, 2024
by Hawaii 2024 Regular Session
|
INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "TREATMENT OF LUPUS"
Published:
April 20, 2024
by U.S. Fed News
|
FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published:
April 19, 2024
by Business Wire
|
Ask us about our Tissue & Hygiene market view